Suchergebnisse - "van Rhee, Frits"

PubPharm (324)

1

Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma

enthalten in: American journal of hematology | 2024

von Mao, X. | Yan, W. | Mery, D. | +16

2

Idiopathic multicentric Castleman disease : An update in diagnosis and treatment advances

enthalten in: Blood reviews | 2024

von Lang, E. | van Rhee, F.

3

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation

enthalten in: Cancers | 2024

von Guo, W. | Strouse, C. | Mery, D. | +18

4

Teclistamab in relapsed refractory multiple myeloma : multi-institutional real-world study

enthalten in: Blood cancer journal | 2024

von Mohan, M. | Monge, J. | Shah, N. | +18

5

Perspectives on the Treatment of Multiple Myeloma

enthalten in: The oncologist | 2024

von Rafae, A. | van Rhee, F. | Al Hadidi, S.

6

The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma

enthalten in: Haematologica | 2024

von Hammons, L. | Szabo, A. | Janardan, A. | +17

7

Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD) : Factors to differentiate from IgG4-related disease

enthalten in: Journal of clinical pathology | 2024

von Nishikori, A. | Nishimura, M. | Fajgenbaum, D. | +13

8

Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma

enthalten in: Bone marrow transplantation | 2024

von Mohan, M. | Szabo, A. | Patwari, A. | +19

9

Prognostic value of ferritin in ASCT MM patients : integration with GEP models and ISS series systems

enthalten in: Blood cancer journal | 2024

von Guo, W. | Zhan, Y. | Mery, D. | +16

10

Three years of maintenance with VRD in multiple myeloma : results of total therapy IIIB with a 15-year follow-up

enthalten in: Blood advances | 2024

von Al Hadidi, S. | Ababneh, O. | Schinke, C. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]